Filtered By:
Specialty: Endocrinology
Condition: Heart Failure
Education: Study
This page shows you your search results in order of relevance. This is page number 16.
Order by Relevance | Date
Total 271 results found since Jan 2013.
Economic Burdens for Treatment of Patients With Type 2 Diabetes in North Thailand: A Hospital-Based Observational Study
ConclusionsDiabetes incurs a substantial financial burden resulting from its complications. Effective management of diabetes with a multi-sectoral effort from government, providers, patients, and private is required.
Source: Frontiers in Endocrinology - May 16, 2022 Category: Endocrinology Source Type: research
Treatment of diabetes mellitus has borne much fruit in the prevention of cardiovascular disease
ABSTRACTCardiovascular (CV) disease is the most alarming complication of diabetes mellitus (DM), and a strategy aiming at CV event prevention in DM has long been debated. Large landmark clinical trials have shown CV benefits of intensive glycemic control as a “legacy effect” in newly diagnosed type 2 DM (T2DM). In contrast, we have learned that excessive intervention aimed at strong glycemic control could cause unexpected CV death in patients who are resistant to treatments against hyperglycemia. It has also been shown that the comprehensive multifac torial intervention for CV risk factors that was advocated in the cur...
Source: Journal of Diabetes Investigation - May 31, 2022 Category: Endocrinology Authors: Hiroaki Yagyu,
Hitoshi Shimano Tags: REVIEW ARTICLE Source Type: research
Risk of cardiovascular events associated with pathophysiological phenotypes of type 2 diabetes
CONCLUSIONS: Simple phenotyping based on insulin sensitivity and beta-cell function predicts distinct future risks of cardiovascular events and death in patients with type 2 diabetes. These results suggest that precision medicine according to underlying type 2 pathophysiology potentially can reduce diabetes complications.PMID:35670619 | DOI:10.1530/EJE-22-0020
Source: European Journal of Endocrinology - June 7, 2022 Category: Endocrinology Authors: Jacob Volmer Stidsen Diana Hedevang Christensen Jan Erik Henriksen Kurt H øjlund Michael Hecht Olsen Reimar Wernich Thomsen Lotte Brix Christensen Jens Steen Nielsen Thomas Bastholm Olesen Henning Beck-Nielsen Source Type: research
Cost-Effectiveness Analysis of Initiating Type 2 Diabetes Therapy with a Sodium–Glucose Cotransporter 2 Inhibitor Versus Conventional Therapy in Japan
ConclusionOur results suggest that initiating T2DM treatment with SGLT2i, aimed at managing cardiovascular and renal complications from the early stages of diabetes, can improve the clinical outcome and reduce cost burden of T2DM.
Source: Diabetes Therapy - June 16, 2022 Category: Endocrinology Source Type: research
Cardiovascular complications of diabetes
Expert Rev Endocrinol Metab. 2022 Jul 13:1-6. doi: 10.1080/17446651.2022.2099838. Online ahead of print.ABSTRACTINTRODUCTION: Type 2 diabetes mellitus (T2DM) is the ninth leading cause of mortality globally, and the prevalence continues to rise. Among individuals with T2DM, over two-thirds of deaths are caused by the cardiovascular complications of diabetes. These complications include atherosclerosis, coronary artery disease, nephropathy, stroke, thromboembolism, peripheral vascular disease. They have been long studied, and there are several theories as to the pathophysiology of how diabetes leads to these complications. ...
Source: Expert Review of Endocrinology and Metabolism - July 14, 2022 Category: Endocrinology Authors: Avisha Shah Ameesh Isath Wilbert S Aronow Source Type: research
New insights into the comorbid conditions of Turner syndrome: results from a long-term monocentric cohort study
ConclusionsThis cohort study confirms the need for continuous, structured and multidisciplinary lifelong monitoring of TS, thus ensuring the early diagnosis of important comorbid conditions, including cancer, and their appropriate and timely treatment. In addition, these data highlight the need for the increased surveillance of specific types of cancer in TS, including thyroid carcinoma.
Source: Journal of Endocrinological Investigation - July 30, 2022 Category: Endocrinology Source Type: research
Major adverse cardiovascular and limb events in people with diabetes treated with GLP-1 receptor agonists vs SGLT2 inhibitors
Conclusions/interpretationIn people with diabetes, GLP1RA use was associated with significantly reduced risks of MALE compared with SGLT2i within the first 2 years after initiation, especially among people with diabetic neuropathy.Graphical abstract
Source: Diabetologia - August 9, 2022 Category: Endocrinology Source Type: research
Diurnal cortisol features with cardiovascular disease in hypertensive patients: a cohort study
CONCLUSIONS: Flatter DCS and higher midnight cortisol levels are associated with an increased risk of CVD in patients with hypertension, especially in men. The detection of diurnal cortisol rhythm may help identify patients with hypertension at high risk of CVD.PMID:36070421 | DOI:10.1530/EJE-22-0412
Source: European Journal of Endocrinology - September 7, 2022 Category: Endocrinology Authors: Lin Gan Nanfang Li Mulalibike Heizati Mengyue Lin Qing Zhu Jing Hong Ting Wu Ling Tong Zuhere Xiamili Yue Lin Source Type: research
